[HTML][HTML] Use of updated COVID-19 vaccines 2023–2024 formula for persons aged≥ 6 months: recommendations of the Advisory Committee on Immunization …

JJ Regan - MMWR. Morbidity and Mortality Weekly Report, 2023 - cdc.gov
COVID-19 vaccines protect against severe COVID-19–associated outcomes, including
hospitalization and death. As SARS-CoV-2 has evolved, and waning vaccine effectiveness …

[HTML][HTML] Use of the Janssen (Johnson & Johnson) COVID-19 vaccine: updated interim recommendations from the advisory committee on immunization practices …

SE Oliver - MMWR. Morbidity and mortality weekly report, 2022 - cdc.gov
On December 16, 2021, after reviewing updated vaccine effectiveness and safety data, the
Advisory Committee on Immunization Practices made a preferential recommendation for the …

[HTML][HTML] Interim recommendations from the Advisory Committee on Immunization Practices for the use of bivalent booster doses of COVID-19 vaccines—United States …

HG Rosenblum - MMWR. Morbidity and mortality weekly report, 2022 - cdc.gov
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use
of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022 | MMWR …

[HTML][HTML] The Advisory Committee on Immunization Practices' recommendation for use of Moderna COVID-19 vaccine in adults aged≥ 18 years and considerations for …

M Wallace - MMWR. Morbidity and Mortality Weekly Report, 2022 - cdc.gov
On February 4, 2022, after a systematic review of the evidence, the Advisory Committee on
Immunization Practices issued a standard recommendation for use of the Moderna COVID …

[HTML][HTML] The advisory committee on immunization practices' interim recommendation for use of moderna COVID-19 vaccine—United States, December 2020

SE Oliver - MMWR. Morbidity and mortality weekly report, 2021 - cdc.gov
On December 19, 2020, after a transparent, evidence-based review of available data, the
Advisory Committee on Immunization Practices (ACIP) issued an interim recommendation …

[HTML][HTML] Interim recommendations for use of bivalent mRNA COVID-19 vaccines for persons aged≥ 6 months—United States, April 2023

DL Moulia - MMWR. Morbidity and Mortality Weekly Report, 2023 - cdc.gov
During December 2022–April 2023, CDC made recommendations for a single bivalent
vaccine dose for most persons aged≥ 6 years, bivalent vaccines for children aged 6 months …

[HTML][HTML] The Advisory Committee on Immunization Practices' interim recommendations for additional primary and booster doses of COVID-19 vaccines—United States …

S Mbaeyi - MMWR. Morbidity and mortality weekly report, 2021 - cdc.gov
The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional
Primary and Booster Doses of COVID-19 Vaccines — United States, 2021 | MMWR Skip directly …

[HTML][HTML] Booster and additional primary dose COVID-19 vaccinations among adults aged≥ 65 years—United States, August 13, 2021–November 19, 2021

HE Fast - MMWR. Morbidity and mortality weekly report, 2021 - cdc.gov
Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years
— United States, August 13, 2021–November 19, 2021 | MMWR Skip directly to site content …

[HTML][HTML] Effectiveness of COVID-19 mRNA vaccines against COVID-19–associated hospitalization—five veterans affairs medical centers, United States, February 1 …

KL Bajema - MMWR. Morbidity and mortality weekly report, 2021 - cdc.gov
During February 1–August 6, 2021, vaccine effectiveness among US veterans hospitalized
at five Veterans Affairs Medical Centers was 87%. mRNA COVID-19 vaccines remain highly …

[HTML][HTML] The advisory committee on immunization practices' interim recommendation for use of Janssen COVID-19 vaccine—United States, February 2021

SE Oliver - MMWR. Morbidity and mortality weekly report, 2021 - cdc.gov
On February 28, 2021, after a transparent evidence-based review of all available data, the
Advisory Committee on Immunization Practices (ACIP) issued an interim recommendation …